These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 28748389

  • 1. Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
    Koh JH, Myong JP, Yoo J, Lim YW, Lee J, Kwok SK, Park SH, Ju JH.
    Osteoporos Int; 2017 Nov; 28(11):3251-3259. PubMed ID: 28748389
    [Abstract] [Full Text] [Related]

  • 2. The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates.
    Sato H, Kondo N, Wada Y, Nakatsue T, Iguchi S, Fujisawa J, Kazama JJ, Kuroda T, Nakano M, Endo N, Narita I.
    Osteoporos Int; 2016 Mar; 27(3):1217-1225. PubMed ID: 26519417
    [Abstract] [Full Text] [Related]

  • 3. High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.
    Sato H, Kondo N, Nakatsue T, Wada Y, Fujisawa J, Kazama JJ, Kuroda T, Suzuki Y, Nakano M, Endo N, Narita I.
    Osteoporos Int; 2017 Aug; 28(8):2367-2376. PubMed ID: 28409215
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Atypical femur fracture during bisphosphonate drug holiday: a case series.
    Lovy AJ, Koehler SM, Keswani A, Joseph D, Hasija R, Ghillani R.
    Osteoporos Int; 2015 Jun; 26(6):1755-8. PubMed ID: 25832177
    [Abstract] [Full Text] [Related]

  • 7. Assessment of bone microarchitecture in postmenopausal women on long-term bisphosphonate therapy with atypical fractures of the femur.
    Zanchetta MB, Diehl M, Buttazzoni M, Galich A, Silveira F, Bogado CE, Zanchetta JR.
    J Bone Miner Res; 2014 Apr; 29(4):999-1004. PubMed ID: 24115250
    [Abstract] [Full Text] [Related]

  • 8. High bisphosphonate treatment rates and the prevalence of atypical femoral fractures in patients with systematic lupus erythematosus: a single-center retrospective study performed in Japan.
    Sato H, Kondo N, Wakamatsu A, Kobayashi D, Nakatsue T, Wada Y, Kuroda T, Suzuki Y, Nakano M, Endo N, Narita I.
    Rheumatol Int; 2019 Oct; 39(10):1803-1810. PubMed ID: 31385078
    [Abstract] [Full Text] [Related]

  • 9. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.
    Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Howe TS, van der Meulen MC, Weinstein RS, Whyte MP.
    J Bone Miner Res; 2014 Jan; 29(1):1-23. PubMed ID: 23712442
    [Abstract] [Full Text] [Related]

  • 10. Lateral Cortical Thickening and Bone Heterogeneity of the Subtrochanteric Femur Measured With Quantitative CT as Indicators for Early Detection of Atypical Femoral Fractures in Long-Term Bisphosphonate Users.
    Lee SH, Lee YH, Suh JS.
    AJR Am J Roentgenol; 2017 Oct; 209(4):867-873. PubMed ID: 28796551
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management.
    Black DM, Abrahamsen B, Bouxsein ML, Einhorn T, Napoli N.
    Endocr Rev; 2019 Apr 01; 40(2):333-368. PubMed ID: 30169557
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Atypical femur fractures.
    Borrelli J, Lane J, Bukata S, Egol KA, Takemoto R, Slobogean G, Morshed S.
    J Orthop Trauma; 2014 Apr 01; 28 Suppl 1():S36-42. PubMed ID: 24476604
    [Abstract] [Full Text] [Related]

  • 16. Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk.
    Mignot MA, Taisne N, Legroux I, Cortet B, Paccou J.
    Osteoporos Int; 2017 Dec 01; 28(12):3431-3438. PubMed ID: 28875236
    [Abstract] [Full Text] [Related]

  • 17. Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study.
    Eisenstein N, Kasavkar G, Bhavsar D, Khan FS, Paskins Z.
    BMC Musculoskelet Disord; 2017 Jan 23; 18(1):29. PubMed ID: 28114975
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.